Wang Y, Li J, Li X, Gao B, Chen J, Song Y
Sci Rep. 2025; 15(1):8055.
PMID: 40055448
PMC: 11889159.
DOI: 10.1038/s41598-025-92607-3.
Damasceno J, Briggs E, Krasilnikova M, Marques C, Lapsley C, McCulloch R
Nat Commun. 2025; 16(1):1470.
PMID: 39922816
PMC: 11807225.
DOI: 10.1038/s41467-025-56785-y.
Longhurst A, Wang K, Suresh H, Ketavarapu M, Ward H, Jones I
Elife. 2025; 13.
PMID: 39903505
PMC: 11793871.
DOI: 10.7554/eLife.97577.
Shi Y, Gilkes D
Cell Mol Life Sci. 2025; 82(1):44.
PMID: 39825916
PMC: 11741981.
DOI: 10.1007/s00018-024-05537-0.
Scully R, Walter J, Nussenzweig A
DNA Repair (Amst). 2024; 144:103783.
PMID: 39504607
PMC: 11681922.
DOI: 10.1016/j.dnarep.2024.103783.
Metachromin C, a marine-derived natural compound, shows potential in antitumor activity.
Chen P, Lee C, Liaw C, Liang R, Khan M, Tsai J
Int J Med Sci. 2024; 21(13):2578-2594.
PMID: 39439453
PMC: 11492879.
DOI: 10.7150/ijms.101037.
Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy.
Kamle M, Pandhi S, Mishra S, Barua S, Kurian A, Mahato D
Med Oncol. 2024; 41(11):263.
PMID: 39382779
DOI: 10.1007/s12032-024-02527-x.
A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.
Froney M, Cook C, Cadiz A, Flinter K, Ledeboer S, Chan B
ACS Pharmacol Transl Sci. 2024; 7(9):2799-2819.
PMID: 39296266
PMC: 11406699.
DOI: 10.1021/acsptsci.4c00251.
Mechanisms controlling replication fork stalling and collapse at topoisomerase 1 cleavage complexes.
Westhorpe R, Roske J, Yeeles J
Mol Cell. 2024; 84(18):3469-3481.e7.
PMID: 39236719
PMC: 7617106.
DOI: 10.1016/j.molcel.2024.08.004.
Induction of homologous recombination by site-specific replication stress.
Triplett M, Johnson M, Symington L
DNA Repair (Amst). 2024; 142:103753.
PMID: 39190984
PMC: 11425181.
DOI: 10.1016/j.dnarep.2024.103753.
Bioprocessing of camptothecin from Alternaria brassicicola, an endophyte of Catharanthus roseus, with a strong antiproliferative activity and inhibition to Topoisomerases.
El-Hady N, ElSayed A, Wadan K, El-Saadany S, El-Sayed A
Microb Cell Fact. 2024; 23(1):214.
PMID: 39060918
PMC: 11282713.
DOI: 10.1186/s12934-024-02471-5.
Potential applications of antofine and its synthetic derivatives in cancer therapy: structural and molecular insights.
Ramli I, Cheriet T, Thuan D, Khoi D, Thu D, Posadino A
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8231-8258.
PMID: 38842561
DOI: 10.1007/s00210-024-03180-x.
Identification of a family of species-selective complex I inhibitors as potential anthelmintics.
Davie T, Serrat X, Imhof L, Snider J, Stagljar I, Keiser J
Nat Commun. 2024; 15(1):3367.
PMID: 38719808
PMC: 11079024.
DOI: 10.1038/s41467-024-47331-3.
Dysfunction of Gpl1-Gih35-Wdr83 Complex in Affects the Splicing of DNA Damage Repair Factors Resulting in Increased Sensitivity to DNA Damage.
Cipakova I, Jurcik M, Selicky T, Lalakova L, Jakubikova J, Cipak L
Int J Mol Sci. 2024; 25(8).
PMID: 38673778
PMC: 11049892.
DOI: 10.3390/ijms25084192.
Dynamics of DNA damage-induced nuclear inclusions are regulated by SUMOylation of Btn2.
Kumar A, Mathew V, Stirling P
Nat Commun. 2024; 15(1):3215.
PMID: 38615096
PMC: 11016081.
DOI: 10.1038/s41467-024-47615-8.
Human AAA+ ATPase FIGNL1 suppresses RAD51-mediated ultra-fine bridge formation.
Matsuzaki K, Shinohara A, Shinohara M
Nucleic Acids Res. 2024; 52(10):5774-5791.
PMID: 38597669
PMC: 11162793.
DOI: 10.1093/nar/gkae263.
Efficiency of Protective Interventions on Irinotecan-Induced Diarrhea: A Systematic Review and Meta-Analysis.
He Y, Wu L, Qi X, Wang X, He B, Zhang W
Integr Cancer Ther. 2024; 23:15347354241242110.
PMID: 38567795
PMC: 10993684.
DOI: 10.1177/15347354241242110.
The PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2.
Longhurst A, Wang K, Suresh H, Ketavarapu M, Ward H, Jones I
bioRxiv. 2024; .
PMID: 38562687
PMC: 10983909.
DOI: 10.1101/2024.03.18.585604.
Screening for cold tolerance genes in C. elegans, whose expressions are affected by anticancer drugs camptothecin and leptomycin B.
Okahata M, Sawada N, Nakao K, Ohta A, Kuhara A
Sci Rep. 2024; 14(1):5401.
PMID: 38443452
PMC: 10914781.
DOI: 10.1038/s41598-024-55794-z.
Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.
Cardillo T, Zalath M, Arrojo R, Sharkey R, Govindan S, Chang C
Oncotarget. 2024; 15:144-158.
PMID: 38386805
PMC: 10883684.
DOI: 10.18632/oncotarget.28559.